Patents Examined by Olayinka Oyeyemi
  • Patent number: 11332798
    Abstract: Disclosed are nucleic acid oligomers, including amplification oligomers, capture probes, and detection probes, for detection of Zika virus nucleic acid. Also disclosed are methods of specific nucleic acid amplification and detection using the disclosed oligomers, as well as corresponding reaction mixtures and kits.
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: May 17, 2022
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Kui Gao, Jeffrey M. Linnen
  • Patent number: 11326202
    Abstract: The present invention provides methods, compositions and kits for enriching and determining nucleotide sequences of a plurality of target loci from a sample comprising nucleic acids. The methods comprise one or more cycles of primer extension followed by PCR amplification of target sequences using nested target-specific primers.
    Type: Grant
    Filed: November 23, 2018
    Date of Patent: May 10, 2022
    Assignee: HELITEC LIMITED
    Inventor: Zongli Zheng
  • Patent number: 11299764
    Abstract: A screening method for the identification of a characteristic of a target nucleic acid in a whole blood sample, including positioning a composition comprising whole blood and at least one preservative agent within a centrifuge, centrifugating the composition to isolate a plasma that includes at least one target nucleic acid for further analysis and analyzing the at least one target nucleic acid to identify a characteristic about the at least one target nucleic acid, and a composition including the plasma, the preservative agent, and any other ingredient, which is produced by the method.
    Type: Grant
    Filed: December 27, 2018
    Date of Patent: April 12, 2022
    Assignee: STRECK, INC.
    Inventors: Bradford A. Hunsley, Jianbing Qin
  • Patent number: 11299769
    Abstract: Provided herein are methods and compositions for the detection of target nucleic acids using target reporter constructs (TRCs) which comprise target sequences complementary to the target nucleic acid. Further provided are methods of replicating the TRCs using rolling circle replication and/or rolling circle amplification to produce replicated TRCs which can be detected using probe sequences within the replicated TRCs.
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: April 12, 2022
    Assignee: REDVAULT BIOSCIENCES, LP
    Inventors: Michael L. Metzker, Christopher August Weier
  • Patent number: 11286517
    Abstract: The present disclosure provides, in some aspects, nucleic acid-based molecular tools that enable the recording of molecular structure and soluble signals as well as the programmed assembly of molecular structures.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: March 29, 2022
    Assignee: President and Fellows of Harvard College
    Inventors: Jocelyn Yoshiko Kishi, Thomas E. Schaus, Peng Yin, Feng Xuan, Nikhil Gopalkrishnan, Sungwook Woo
  • Patent number: 11286522
    Abstract: The present disclosure relates to systems and methods for high efficiency electronic sequencing of nucleic acids and molecular detection.
    Type: Grant
    Filed: August 20, 2018
    Date of Patent: March 29, 2022
    Assignee: GENAPSYS, INC.
    Inventor: Hesaam Esfandyarpour
  • Patent number: 11268156
    Abstract: Disclosed are methods for diagnosing Bacterial Vaginosis in a subject comprising performing an assay for the detection of any one or more of Lactobacillus sp., Gardneralla vaginalis, and Eggerthella sp. in a subject sample. Also disclosed are methods and compositions for detecting Lactobacillus sp., Gardneralla vaginalis, and/or Eggerthella nucleic acid in a sample.
    Type: Grant
    Filed: December 11, 2019
    Date of Patent: March 8, 2022
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Barbara Lynn Eaton, Damon Kittredge Getman, Traci Pawlowski
  • Patent number: 11248262
    Abstract: The invention refers to a novel method of preparing strand-specific RNA-sequencing libraries that can be used to identify DNA coding and non-coding strands that are transcribed to RNA. Such strand-specific RNA-sequencing libraries are especially useful in discovering anti-sense RNA and non-coding RNA. Random primer oligonucleotides, covalently coupled to a moiety, which blocks ligation, are used for RT reaction or the subsequent generation of the second DNA strand so that only one strand of the generated double-stranded DNA is ligated to sequencing adapters at the 5? nucleotide and sequenced by paired-end sequencing.
    Type: Grant
    Filed: August 24, 2016
    Date of Patent: February 15, 2022
    Assignee: QIAGEN GmbH
    Inventors: Nan Fang, Bernhard Noll, Katja Heitz
  • Patent number: 11225693
    Abstract: Provided herein are compositions and methods for diagnosing and characterizing tuberculosis infection. In particular, provided herein are compositions and methods for identifying drug resistant tuberculosis.
    Type: Grant
    Filed: November 22, 2019
    Date of Patent: January 18, 2022
    Assignee: ABBOTT MOLECULAR INC.
    Inventors: Hong Wang, Gregor W. Leckie, Vihanga Pahalawatta, Klara Abravaya, Joshua Kostera, Ning Tang, Andrea Frank
  • Patent number: 11220719
    Abstract: This disclosure provides oligomers, compositions, and kits for detecting and quantifying Hepatitis B virus (HBV), including different genotypes and variants thereof, and related methods and uses. In some embodiments, oligomers target the P and/or S open reading frames of HBV and are configured to provide substantially equivalent quantification of different genotypes and variants of HBV.
    Type: Grant
    Filed: November 1, 2019
    Date of Patent: January 11, 2022
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Kui Gao, Jeffrey M. Linnen
  • Patent number: 11214829
    Abstract: Described herein are methods, compositions, kits, and uses thereof for analysis of nucleic acid segments comprising a repeating A/T-rich segment, wherein the repeating A/T-rich segment is: (i) a homopolymeric segment comprising at least 10 A residues, at least 10 T residues, or at least 10 U residues, wherein the at least 10 A, T, or U residues are consecutive or interrupted once by one to three other nucleotides; or (ii) a segment comprising (TnA)m, (ATn)m, (TAn)m, or (AnT)m, wherein n is 2 or greater and m is such that the length of the repeating A/T-rich segment is 10 or more residues.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: January 4, 2022
    Assignee: ASURAGEN, INC.
    Inventors: Gary J. Latham, Sachin Sah
  • Patent number: 11186865
    Abstract: A method of simultaneously analyzing RNA and DNA in a sample, the method comprising the step (a) contacting the sample with a reverse primer from a first primer pair directed to a target RNA region to effect reverse transcription of RNA into cDNA with a reverse transcriptase; (b) subsequently contacting the sample with (i) a forward primer from the first primer pair directed to a second cDNA region, (ii) a forward and a reverse primers from a second primer pair targeted to a DNA region, and (ii) a DNA polymerase to simultaneously amplify the target cDNA and target DNA region; and (c) analyzing the amplified target cDNA region and/or amplified target DNA region. Also encompassed are uses of the method to analyze gene expression and mutations, kits comprising primers, enzymes, buffers.
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: November 30, 2021
    Assignee: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Min-Han Tan, Igor Cima
  • Patent number: 11186864
    Abstract: This invention relates to compositions, methods and kits for detecting the presence or absence of a bacterial species in a biological sample using isothermal nucleic acid amplification.
    Type: Grant
    Filed: May 20, 2019
    Date of Patent: November 30, 2021
    Assignee: IONIAN TECHNOLOGIES, LLC
    Inventors: Daiwei Shen, Richard Roth, Honghua Zhang
  • Patent number: 11180787
    Abstract: Methods for amplification of a target nucleic acid sequence comprising strand invasion are provided in which strand invasion occurs both at upstream and downstream regions of the target nucleic acid sequence. Further provided are kits and compositions suitable for use in such methods. The methods may comprise amplifying a target nucleic acid sequence comprising a region of unknown sequence, or determining the sequence of a target nucleic acid comprising a region of unknown sequence.
    Type: Grant
    Filed: June 3, 2015
    Date of Patent: November 23, 2021
    Assignee: AIDIAN OY
    Inventors: Kevin Eboigbodin, Mirko Brummer
  • Patent number: 11174510
    Abstract: The present invention is directed to methods, compositions and software for enriching low abundance alleles in a sample. It is directed in particular to the use of an excess amount of reference blocking sequence in an amplification reaction mixture in order to improve the enrichment efficiency, and reduce cycle time, of full COLD-PCR.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: November 16, 2021
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventor: Gerassimos Makrigiorgos
  • Patent number: 11155883
    Abstract: The invention provides DNA compositions that relate to transgenic insect resistant maize plants. Also provided are assays for detecting the presence of the maize DP-004114-3 event based on the DNA sequence of the recombinant construct inserted into the maize genome and the DNA sequences flanking the insertion site. Kits and conditions useful in conducting the assays are provided.
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: October 26, 2021
    Inventors: Scott Diehn, Albert L Lu, Timothy M Nowatzki, Douglas S Nubel, M Alejandra Pascual, James C Register, III, Christopher J Scelonge, Joshua K Young, Cathy Xiaoyan Zhong, Erin L Crowgey
  • Patent number: 11155864
    Abstract: A method including steps of (a) providing an array of sites, wherein each site comprises a mixture of different nucleic acid templates; (b) extending primers hybridized to the different nucleic acid templates at each of the sites with different nucleotide analogs having different reversible blocking moieties, respectively, thereby producing different primer extension products at each site; (c) detecting the different primer extension products to distinguish the different nucleotide analogs at each site; and (d) removing the different reversible blocking moieties from the primer extension products at each of the sites using a first treatment that is selective for a first of the different reversible blocking moieties and a second treatment that is selective for a second of the different reversible blocking moieties.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: October 26, 2021
    Assignee: Illumina, Inc.
    Inventors: Eliane H Trepagnier, Tarun Khurana
  • Patent number: 11136616
    Abstract: Disclosed are compositions and methods for the preparation of RNA libraries for sequencing, gene expression profiling, microarray and other uses and for simplification of the library preparation process. The disclosure provides blocking oligonucleotides which bind to byproduct nucleic acid molecules formed during the ligation of adapters to nucleic acid segments prior to sequencing and inhibit or block amplification of the byproduct nucleic acid molecules in subsequent amplification reactions. Methods for library preparation using blocking oligonucleotides are also provided.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: October 5, 2021
    Assignee: Life Technologies Corporation
    Inventors: Jian Gu, Kelli Bramlett, Christopher Burnett
  • Patent number: 11118237
    Abstract: Disclosed are nucleic acid oligomers for amplifying one or more selected regions of HCV nucleic acid. Also disclosed are methods for specific amplification and characterization of HCV nucleic acid using the disclosed oligomers, as well as corresponding reaction mixtures and kits.
    Type: Grant
    Filed: December 6, 2018
    Date of Patent: September 14, 2021
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Reinhold B. Pollner, Shyun-Shyun Lee
  • Patent number: 11118232
    Abstract: Described herein are methods for diagnosing melanoma or basal cell carcinoma based on mutations in the DDR2 gene. Further, a distinct subgroup of BRAF-mutated melanomas have somatic mutations in the DDR2 gene as well. Applications of this finding to routine diagnostics include the molecular stratification of melanoma, and the tissue identification of targetable DDR2 kinase mutations in routine formalin-fixed paraffin-embedded sections. Described herein are methods, compositions and kits related to the discovery that DDR2 mutations may be markers for melanoma generally, and BRAF-mediated melanoma in particular, opening up the possibility of dual therapy for melanoma by targeting both DDR2 and BRAF.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: September 14, 2021
    Assignee: Quest Diagnostics Investments LLC
    Inventors: Daniel M. Jones, Yongbao Wang, Shere Billouin-Frazier, Justin Windham